Literature DB >> 1721042

Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets.

A Bajpai1, B S Kwon, Z Brahmi.   

Abstract

We have previously reported that cytotoxic lymphocytes, when exposed to sensitive target cells, temporarily lose their lytic potential. The mechanism leading to this loss of lytic activity is still unknown but it is reversible and the lytic potency can be recovered when the effector cells are incubated with interleukin-2 (IL-2) for 12-14 hr. In this study, we have investigated the regulation of RNA coding for perforin and for two serine proteases, HSP1 and HSP2, in cytotoxic lymphocytes exposed to sensitive targets. Perforin and the two serine proteases are contained in granules of major histocompatibility complex (MHC)-restricted and non-MHC-restricted cytotoxic lymphocytes, but their exact role in the lytic mechanism is still debated. Here we used four different human cytotoxic lymphocytes (CTL) as effector cells: an MHC-restricted CTL (SG-CTL), a non-MHC-restricted CTL (IE6), a natural killer (NK)-like cell line (3.3) and lymphokine-activated killer (LAK) cells. In all effector cells we observed a rapid loss of perforin and of serine protease RNAs within 5 min following the addition of sensitive targets. The effector cells recovered the RNA messages as early as 30 min, although the kinetics of recovery was faster with CTL than with NK-like or LAK effector cells. When we exposed the effector cells to resistant targets we did not detect any loss of perforin or serine protease RNAs. Incubation of the effector cells with cycloheximide, prior to the addition of sensitive targets, did not block message loss, indicating that de novo protein synthesis was not required in this process. Cycloheximide treatment, however, inhibited the recovery of perforin and serine protease RNAs. Taken together, our results indicate that the target-mediated loss of lytic activity in cytotoxic lymphocytes may be a consequence of the down-regulation of perforin or of serine protease transcripts, or both.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721042      PMCID: PMC1384602     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  A study of proteolysis as a possible mechanism for T-cell-mediated target cell lysis.

Authors:  A Matter
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

Review 2.  Killing of target cells by lymphocytes: a mechanistic view.

Authors:  J D Young
Journal:  Physiol Rev       Date:  1989-01       Impact factor: 37.312

3.  The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities.

Authors:  J D Young; Z A Cohn; E R Podack
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

4.  Target cell-directed inactivation and IL-2-dependent reactivation of LAK cells.

Authors:  J Xiao; Z Brahmi
Journal:  Cell Immunol       Date:  1989-09       Impact factor: 4.868

5.  A melanocyte-specific complementary DNA clone whose expression is inducible by melanotropin and isobutylmethyl xanthine.

Authors:  B S Kwon; R Halaban; G S Kim; L Usack; S Pomerantz; A K Haq
Journal:  Mol Biol Med       Date:  1987-12

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  Cloning, analysis, and expression of murine perforin 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9.

Authors:  D M Lowrey; T Aebischer; K Olsen; M Lichtenheld; F Rupp; H Hengartner; E R Podack
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

8.  Cloning and chromosomal assignment of a human cDNA encoding a T cell- and natural killer cell-specific trypsin-like serine protease.

Authors:  H K Gershenfeld; R J Hershberger; T B Shows; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

9.  Target cell directed NK inactivation. Concomitant loss of NK and antibody-dependent cellular cytotoxicity activities.

Authors:  S I Abrams; Z Brahmi
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

10.  Isolation and sequence analysis of serine protease cDNAs from mouse cytolytic T lymphocytes.

Authors:  B S Kwon; D Kestler; E Lee; M Wakulchik; J D Young
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  1 in total

Review 1.  NK Cell Hyporesponsiveness: More Is Not Always Better.

Authors:  Marie Frutoso; Erwan Mortier
Journal:  Int J Mol Sci       Date:  2019-09-12       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.